Editorial: a pipe dream fulfilled? A therapeutic option for fatigue in IBD. Authors' reply

被引：0
|
作者：
Bager, Palle [1 ]
Hvas, Christian Lodberg [1 ]
Rud, Charlotte Lock [1 ]
Dahlerup, Jens Frederik [1 ]
机构：
[1] Aarhus Univ Hosp, Dept Gastroenterol & Hepatol, Aarhus N, Denmark
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2021年 / 53卷 / 02期
关键词：
D O I：
10.1111/apt.16209
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：344 / 345
页数：2
相关论文
共 30 条
  • [11] Editorial: colorectal cancer in elderly-onset IBD-what is the risk? Authors' reply
    Everhov, Asa H.
    Olen, Ola
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (09) : 1423 - 1424
  • [12] Editorial: 5-ASA in IBD patients on biologics-'stop or continue'? Authors' reply
    Bernstein, Charles N.
    Tennakoon, Aruni
    Singh, Harminder
    Targownik, Laura
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (06) : 845 - 845
  • [13] Editorial: fatigue-difficult to assess and difficult to treat. Authors' reply
    Schreiner, Philipp
    von Kanel, Roland
    Misselwitz, Benjamin
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (02) : 340 - 341
  • [14] Editorial: The impact of COVID on the management of IBD flares: Different care but similar outcomes-Authors' reply
    Saifuddin, Aamir
    Kent, Alexandra J.
    Mehta, Shameer J. J.
    Sebastian, Shaji
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (01) : 156 - 157
  • [15] Editorial: quality assessment in IBD in high resource countries can lead to quality improvement clues for IBD management worldwide-authors' reply
    Hawthorne, A. Barney
    Lamb, Christopher A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (04) : 743 - 743
  • [16] Editorial: proactive anti-TNF drug monitoring in IBD--Ready for the prime time? Authors' reply
    Sethi, Sonika
    Kumar, Aditi
    Dias, Shiluka
    Blackwell, Jonathan
    Brookes, Matthew J.
    Segal, Jonathan P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (12) : 1455 - 1456
  • [17] Editorial: Pip pip to PIPs (post- inflammatory polyps) as a neoplasia risk factor in IBD? Authors' reply
    Kirchgesner, Julien
    Beaugerie, Laurent
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (03) : 363 - 363
  • [18] Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic-authors' reply
    King, Dominic Stephen
    Trudgill, Nigel John
    Adderley, Nicola J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (12) : 1442 - 1443
  • [19] Editorial: impaired fasting pyloric compliance in gastroparesis and the benefits of therapeutic pyloric dilatation - authors' reply
    Gourcerol, G.
    Ducrotte, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (09) : 908 - 908
  • [20] Editorial: pressure to close the therapeutic window of non-selective beta blockers? Authors' reply
    Tergast, Tammo L.
    Maasoumy, Benjamin
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (08) : 958 - 960
123